A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 20 May 2016
At a glance
- Drugs MEDI 0457 (Primary) ; Cisplatin
- Indications Cervical cancer
- Focus Adverse reactions; Therapeutic Use
- 12 May 2016 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 14 Jan 2016 Planned End Date changed from 1 Dec 2020 to 1 May 2021 as per ClinicalTrials.gov record.
- 14 Jan 2016 Planned primary completion date changed from 1 Dec 2018 to 1 May 2019 as per ClinicalTrials.gov record.